BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26732212)

  • 1. [Brain damage caused by exposure to organic solvents; diagnostics and disease course of chronic solvent-induced encephalopathy].
    van Valen E; van Hout ES; Wekking EM; Lenderink AF; van der Laan G; Hageman G
    Ned Tijdschr Geneeskd; 2015; 159():A9431. PubMed ID: 26732212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotoxicity of solvents.
    Sainio MA
    Handb Clin Neurol; 2015; 131():93-110. PubMed ID: 26563785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic solvent-induced encephalopathy: European consensus of neuropsychological characteristics, assessment, and guidelines for diagnostics.
    van Valen E; van Thriel C; Akila R; Nilson LN; Bast-Pettersen R; Sainio M; van Dijk F; van der Laan G; Verberk M; Wekking E
    Neurotoxicology; 2012 Aug; 33(4):710-26. PubMed ID: 22498091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision rules for assessment of chronic solvent-induced encephalopathy: Results in 2370 patients.
    Verberk MM; van der Hoek JA; van Valen E; Wekking EM; van Hout MS; Hageman G; van der Laan G; van Dijk FJ
    Neurotoxicology; 2012 Aug; 33(4):742-52. PubMed ID: 22722000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myoclonic seizure prior to diagnosis of chronic toxic encephalopathy: a case report.
    Van Hooste WL
    J Med Case Rep; 2017 Feb; 11(1):36. PubMed ID: 28173825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Solvent-induced chronic encephalopathy; the 'solvent team' project].
    van der Hoek JA; Verberk MM; van der Laan G; Hageman G
    Ned Tijdschr Geneeskd; 2001 Feb; 145(6):256-60. PubMed ID: 11236371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
    van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
    Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solvent-related chronic toxic encephalopathy as a target in the worker's mental health research.
    Ramos A; Jardim SR; Silva-Filho JF
    An Acad Bras Cienc; 2004 Dec; 76(4):757-69. PubMed ID: 15558155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic solvent-induced encephalopathy: course and prognostic factors of neuropsychological functioning.
    van Valen E; Wekking E; van Hout M; van der Laan G; Hageman G; van Dijk F; de Boer A; Sprangers M
    Int Arch Occup Environ Health; 2018 Oct; 91(7):843-858. PubMed ID: 29943196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic solvent induced chronic toxic encephalopathy: extent of recovery, and associated factors, following cessation of exposure.
    Dryson EW; Ogden JA
    Neurotoxicology; 2000 Oct; 21(5):659-65. PubMed ID: 11130269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychological disturbances after controlling for insufficient effort.
    van Hout MS; Schmand B; Wekking EM; Deelman BG
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):296-303. PubMed ID: 16484635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic solvent induced encephalopathy: a step forward.
    van der Laan G; Sainio M
    Neurotoxicology; 2012 Aug; 33(4):897-901. PubMed ID: 22560998
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute toxic encephalopathy induced by occupational exposure to 1,2-dichloropropane.
    Kwak KM; Jeong KS; Shin DH; Choi WJ; Kim HS; Kang SK
    Ind Health; 2018 Nov; 56(6):561-565. PubMed ID: 29973469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serum S100B and neuron specific enolase levels to evaluate the neurotoxıc effects of organıc solvent exposure.
    Züngün C; Yilmaz FM; Tutkun E; Yilmaz H; Uysal S
    Clin Toxicol (Phila); 2013; 51(8):748-51. PubMed ID: 23889347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of detecting a chronic solvent encephalopathy case by screening.
    Furu H; Sainio M; Ahonen G; Hyvärinen HK; Kaukiainen A
    Neurotoxicology; 2014 Dec; 45():253-9. PubMed ID: 24463353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inclusion of psychopathologic methods for diagnosis of early neurotoxic effects from lead and organic solvent mixtures].
    Pfister E; Böckelmann I; Darius S; Wurthmann C
    Fortschr Neurol Psychiatr; 1999 Oct; 67(10):435-40. PubMed ID: 10596364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Euroquest: the validity of a new symptom questionnaire.
    Karlson B; Osterberg K; Orbaek P
    Neurotoxicology; 2000 Oct; 21(5):783-9. PubMed ID: 11130283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The course of chronic solvent induced encephalopathy: a systematic review.
    van Valen E; Wekking E; van der Laan G; Sprangers M; van Dijk F
    Neurotoxicology; 2009 Nov; 30(6):1172-86. PubMed ID: 19538991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.